ASTELLAS PHARMA US, INC

• ASTELLAS PHARMA US, INC. $4,160,000 In-house, the client's own filings · 6 filings
• TARPLIN, DOWNS & YOUNG, LLC $480,000 Outside firm · 6 filings
• THEGROUP DC, LLC $420,000 Outside firm · 6 filings
• TIBER CREEK GROUP $360,000 Outside firm · 6 filings
• TODD STRATEGY GROUP $300,000 Outside firm · 6 filings
• JEFFREY J. KIMBELL & ASSOCIATES, INC. $240,000 Outside firm · 6 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

• HR 1300
  PSA Screening for HIM Act
  11 filings
• S 297
  PSA Screening for HIM Act
  6 filings
• HR 946
  ORPHAN Cures Act
  2 filings
• S 1862
  ORPHAN Cures Act
  2 filings
• HR 5376
  Impacts and Outcomes for Health Career Training Act
  1 filing
• HRES 1090
  Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month".
  1 filing
• S 392
  Sloan Canyon Conservation and Lateral Pipeline Act
  1 filing

• 2026 $1,700,000 12 filings
• 2025 $4,260,000 24 filings

• Health Issues 36
• Medicare/Medicaid 12
• Pharmacy 12
• Copyright/Patent/Trademark 6
• Taxation/Internal Revenue Code 5
• Insurance 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

• HOUSE OF REPRESENTATIVES 36
• SENATE 36
• Centers For Medicare and Medicaid Services (CMS) 7
• Natl Institutes of Health (NIH) 6